一品红：子公司获得磷酸奥司他韦胶囊药品补充申请批准通知书

Core Viewpoint - The company has received approval from the National Medical Products Administration for the addition of a new specification of Oseltamivir Phosphate Capsules, indicating a positive development in its product portfolio [1] Group 1: Product Approval - The company's wholly-owned subsidiary, Guangzhou Yipinhong Pharmaceutical Co., Ltd., has been granted a Drug Supplement Application Approval Notice for Oseltamivir Phosphate Capsules [1] - The approval includes the addition of a 30mg specification for the product, which expands its market offerings [1] - The approval also encompasses related supplementary applications, including changes to registration standards and production processes [1]